Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
OncLive TV: Neeraj Agarwal, MD
<< Back to Our Featured Experts
Dr. Agarwal on the QoL With Apalutamide in Metastatic Castration-Sensitive Prostate Cancer
Dr. Agarwal on the Safety Profile of Enzalutamide/Talazoparib in mCRPC
Dr. Agarwal on Patient Selection in Frontline Advanced RCC
Dr. Agarwal on Updated Results of the JAVELIN Renal 101 Trial in Advanced RCC
Dr. Agarwal on Unmet Needs in mRCC
Dr. Agarwal on the Combination of Lenvatinib and Everolimus in mRCC
Dr. Agarwal Discusses Results of KEYNOTE-426 in mRCC
Dr. Agarwal on Second-Line Therapy Selection in Metastatic RCC
Dr. Agarwal on Next Steps in Kidney Cancer
Dr. Agarwal on Emerging Immunotherapeutic Combinations in Kidney Cancer
Dr. Agarwal on Frontline Treatment in Kidney Cancer
Dr. Agarwal Discusses Recent FDA Approvals in RCC
Dr. Agarwal on Treatment for Newly Diagnosed Prostate Cancer
Dr. Agarwal on the Advantages of Docetaxel in Prostate Cancer
Dr. Agarwal on the CheckMate-214 Trial for Kidney Cancer
Dr. Agarwal on Androgen Receptor Inhibitors for Prostate Cancer
Dr. Agarwal on Remaining Questions With Renal Cell Carcinoma
Dr. Agarwal on Potential Agents for Metastatic Hormone-Sensitive Prostate Cancer
Dr. Agarwal on the STAMPEDE and LATITUDE Trials for Prostate Cancer
Dr. Agarwal on Toxicities With Checkpoint Inhibitors in RCC
Dr. Neeraj Agarwal on PROSTVAC and Other Immunotherapies in Prostate Cancer
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Cristi Radford, MS, CGC
Jerald P. Radich, MD
Luis E. Raez, MD
Saeed Rafii, MD, PhD
Kanwal Raghav, MBBS, MD
Mohammed Rahman, MD
Mohammed J. Rahman, MD
Kanti R. Rai, MD
Lakshmi N. Rajdev, MD
Noopur Raje, MD
Noopur S. Raje, MD
S. Vincent Rajkumar, MD
Suresh A. Ramalingam, MD
Suresh S. Ramalingam, MD
Suresh S. Ramalingam
Jay D. Raman, MD
Ramesh K. Ramanathan, MD
Sridhar Ramaswamy, MD
ramaswamy
Robert Ramirez, DO, FACP
Huma Q. Rana, MD
Leslie M. Randall, MD
R. Lor Randall, MD, FACS
Gregory W. Randolph, MD
Harsha Ranganath, MD
Jianyu Rao, MD
Ruta Rao, MD
Ruta D. Rao, MD
Rekha Rao, PhD
Bernardo L. Rapoport, MD
Frederick Alan Rapoport, MD
Anastasios Raptis, MD
Jasmine Rassiwala, MD
Art Rastinehad, DO
Dana E. Rathkopf, MD
Farhad Ravandi, MD
Farhad Ravandi-Kashani, MD
Walter Rayford, MD, PhD, MBA
Dan J. Raz, MD
Evangelia Razis, MD, PhD
Neal E. Ready, MD, PhD
David A. Reardon, MD
Martin Reck, MD
Karen Reckamp, MD
Karen Reckamp, MD, MS
Robert L. Redner, MD
Craig B. Reeder, MD
Diane Reidy-Lagunes, MD
Niels Reinmuth, MD, PhD
Markus Renschler, MD
Joseph F. Renzulli, II, MD, FACS
Juan A. Reyna, MD
Antoni Ribas, MD, PhD
Laurel W. Rice, MD
Kyle A. Richards, MD
Donald A. Richards, MD, PhD
Kristin J. Richardson, MD
Paul Richardson, MD
Paul G. Richardson, MD
Joshua Richter, MD
Richard F. Riedel, MD
Gregory Riely, MD
Jonathan Riess, MD
Jonathan Riess, MD, MS
Robert M. Rifkin, MD
Mothaffar F. Rimawi, MD
David L. Rimm, MD, PhD
Alexander Ring, MD
Brian I. Rini, MD
Brian I. Rini, MD,
Danny Rischin, MD
Danny Rischin, MD, MBBS, FRACP
M. Patricia Rivera, MD
Nabil P. Rizk, MD, MS, MPH
Naiyer A. Rizvi, MD
J. Douglas Rizzo, MD, MS
Nicholas J. Robert, MD
Caroline Robert, MD, PhD
Lewis R. Roberts, MB, ChB, PhD
Jane Robertson, MD
Gail Roboz, MD
Gail J. Roboz, MD
Mark E. Robson, MD
Cristina P. Rodriguez, MD
Kerry Rogers, MD
Christian Rolfo, MD, PhD
Christian Rolfo, MD, PhD, MHBA
Arantxa Romero-Toledo, PhD
Mark J. Roschewski, MD
Steven T. Rosen, MD
Johnathan E. Rosenberg, MD
Jonathan E. Rosenberg, MD
Steven A. Rosenberg, MD, PhD
Barry Rosenbloom, MD
Allison C. Rosenthal, DO
Michael Rosenzweig, MD
Ashley Rosko, MD
Malcolm Ross, MD
Merrick I. Ross, MD
James M. Rossetti, DO
Bruce Roth, MD
Jack A. Roth, MD
Joshua Roth, PhD
Michael Rotkowitz, MD
Scott Rowley, MD
Melanie E. Royce, MD, PhD
Jia Ruan, MD, PhD
Jia Ruan, MD, PhD,
Mark A. Rubin, MD
Krista Rubin, MS, RN, FNP-BC
Kathryn Ruddy, MD
Charles M. Rudin, MD
Charles M. Rudin, MD, PhD
Paul Ruff, MD
Hope Rugo, MD
Hope S. Rugo, MD
Marco Ruiz, MD
Simon Rule, MD
Simon Rule, MD, PhD
Mathias J. Rummel, MD, PhD
Lyndsey Runaas, MD
Emiel J. Rutgers, MD
Charles J. Ryan, MD
OncLive News Network On Location: ASH 2019 Day 3
Trending Now
Dr. Murthy on HER2CLIMB Trial Results in HER2+ Breast Cancer
Residual Cancer Burden Predicts Patient Outcomes Across Breast Cancer Subtypes
ROS1-Rearranged NSCLC
Tucatinib Boosts Survival in HER2+ Breast Cancer, FDA Submission Imminent
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe